SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001629137-16-000026
Filing Date
2016-03-29
Accepted
2016-03-29 07:37:17
Documents
3
Period of Report
2016-03-29
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a4q15form8-k.htm 8-K 35468
2 EXHIBIT 99.1 a4q15form8-kexhibit991.htm EX-99.1 89775
3 gbtlogoa02.jpg GRAPHIC 25709
  Complete submission text file 0001629137-16-000026.txt   161881
Mailing Address 400 EAST JAMIE COURT, SUITE 101 SOUTH SAN FRANCISCO CA 94080
Business Address 400 EAST JAMIE COURT, SUITE 101 SOUTH SAN FRANCISCO CA 94080 650741-7700
Global Blood Therapeutics, Inc. (Filer) CIK: 0001629137 (see all company filings)

IRS No.: 274825712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37539 | Film No.: 161533598
SIC: 2834 Pharmaceutical Preparations